Key facts
- This page summarizes Phillips T. Danny's Form 4 filing for Caris Life Sciences, Inc..
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Sep 2025, 16:29.
Phillips T. Danny - 11 Sep 2025 Form 4 Insider Report for Caris Life Sciences, Inc.
- Reporting relationship
- Director
- Issuer ticker
- CAI on Nasdaq
- Reported as of
- 11 Sep 2025
- Net transaction value
- +$244,000
- SEC form
- 4
- Accepted by SEC
- 12 Sep 2025, 16:29:39 UTC
- Prior SEC filing
- 17 Jun 2025
- Next SEC filing
- 27 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ J. Russel Denton, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Phillips T. Danny filed Form 4 for Caris Life Sciences, Inc. on 12 Sep 2025.
Change
- Previous filing in this sequence was filed on 17 Jun 2025.
- Current net transaction value: +$244,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001239690
Primary reporting owner
PHILLIPS T DANNY
- Relationship
- Director
- Address
- C/O CARIS LIFE SCIENCES, INC., 750 W. JOHN CARPENTER FREEWAY, SUITE 800, IRVING
- Signature
- /s/ J. Russel Denton, Attorney-in-Fact
- Signature date
- 12 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CAI
transaction
Common Stock
Options Exercise
- Transaction value
- $244,000
- Shares
- +100,000
- Change %
- +620%
- Price
- $2.44
- Shares after
- 116,129
- Date
- 11 Sep 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CAI
transaction
Derivative
Stock Option
Options Exercise
- Transaction value
- $0
- Shares
- -100,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Sep 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 100,000
- Exercise price
- $2.44
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option is fully vested and exercisable.